Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2875

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms ; volume:17 ; number:1 ; day:22 ; month:1 ; year:2018 ; pages:1-6 ; date:12.2018
Malaria journal ; 17, Heft 1 (22.1.2018), 1-6, 12.2018

Keyword: Infektion
Infektiologie

Creator: Baird, J. Kevin

Contributor: Battle, Katherine E.
Howes, Rosalind E.
SpringerLink (Online service)

DOI: 10.1186/s12936-018-2190-z

URN: urn:nbn:de:1111-201803213927

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Baird, J. Kevin
Battle, Katherine E.
Howes, Rosalind E.
SpringerLink (Online service)

Other Objects (12)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Barriers to routine G6PD testing prior to treatment with primaquine

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Geographical variation in Plasmodium vivax relapse

The global distribution of Plasmodium vivax and G6PD deficiency prevalence

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Primaquine in vivax malaria: an update and review on management issues

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Barriers to routine G6PD testing prior to treatment with primaquine

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Geographical variation in Plasmodium vivax relapse

The global distribution of Plasmodium vivax and G6PD deficiency prevalence

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Primaquine in vivax malaria: an update and review on management issues

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Barriers to routine G6PD testing prior to treatment with primaquine

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Geographical variation in Plasmodium vivax relapse

The global distribution of Plasmodium vivax and G6PD deficiency prevalence

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Primaquine in vivax malaria: an update and review on management issues

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Barriers to routine G6PD testing prior to treatment with primaquine

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Geographical variation in Plasmodium vivax relapse

The global distribution of Plasmodium vivax and G6PD deficiency prevalence

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Primaquine in vivax malaria: an update and review on management issues

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Barriers to routine G6PD testing prior to treatment with primaquine

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Geographical variation in Plasmodium vivax relapse

The global distribution of Plasmodium vivax and G6PD deficiency prevalence

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Primaquine in vivax malaria: an update and review on management issues

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Barriers to routine G6PD testing prior to treatment with primaquine

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Geographical variation in Plasmodium vivax relapse

The global distribution of Plasmodium vivax and G6PD deficiency prevalence

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Primaquine in vivax malaria: an update and review on management issues

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Related objects

Reset password